PureTech Health PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, everyone, and welcome to the 39th Annual JPMorgan Healthcare Conference. My name is [Vedder Schader]. I'm a Vice President in our health care investment banking team. And it's my pleasure today to introduce you to our next presenting company, that is PureTech. And we have our next presenter, Daphne Zohar, the founder and CEO of PureTech.
Before we start, though, I'd just like to mention that we'll -- after the prepared remarks, we'll have about 10 to 15 minutes of Q&A, and you'll be able to submit a question through the link on the website, the blue Submit A Question button.
And with that, I'll hand it over to Daphne.
Thank you, [Vedder], and to the JPMorgan team for inviting us to present, and welcome to everyone who is listening and watching via webcast.
We have a very unique story to tell at PureTech. And importantly, we have a highly promising wholly-owned therapeutic development pipeline that we're going to dig into during
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |